← Leaderboards
Liyun Zhang
Johns Hopkins University
$2,034,594
Attributed
$2,034,594
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $409.4K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,034,594 · 1
By mechanism
R01$2,034,594 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Peter A Campochiaro$21,020,539
- King-Wai Yau$28,664,002
- Karl J Wahlin$4,616,531
- Donald J Zack$29,428,568
- Erica Ellen Davis$13,061,629
Others in their field
Other Emerging Leaders on “Etiology”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$35,120,637
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$21,969,486
- Emmanuel Aja Oga · Research Triangle Institute$16,110,065
- Vanessa Rivera-Amill · Ponce School Of Medicine$12,587,042
- Julie Stoner · University Of Oklahoma Hlth Sciences Ctr$12,318,552
- Alberto Rafael Ramos · University Of Miami School Of Medicine$11,170,423
Research focus
EtiologyDrug TargetingAffectDrug ScreeningBehaviorBiological ModelsBlindnessCategoriesDrug ModelingsCell Death ProcessCellsCell SurvivalCessation Of LifeClinical TrialsCrispr/Cas TechnologyDegenerative DisorderDisease ModelDisease PathwayCell DeathDoseDrug CandidateDrug Delivery SystemsDrug DiscoveryExhibits
Grant awards (6)
Drug Screening for Neuroprotectants in Novel Zebrafish Models of Retinitis Pigmentosa$409,375
R01 · FY2025 · EY · contact PI
Drug Screening for Neuroprotectants in Novel Zebrafish Models of Retinitis Pigmentosa$291,964
R01 · FY2024 · EY · contact PI
Drug Screening for Neuroprotectants in Novel Zebrafish Models of Retinitis Pigmentosa$117,411
R01 · FY2024 · EY · contact PI
Drug Screening for Neuroprotectants in Novel Zebrafish Models of Retinitis Pigmentosa$409,375
R01 · FY2023 · EY · contact PI
Drug Screening for Neuroprotectants in Novel Zebrafish Models of Retinitis Pigmentosa$397,094
R01 · FY2022 · EY · contact PI
Drug Screening for Neuroprotectants in Novel Zebrafish Models of Retinitis Pigmentosa$409,375
R01 · FY2021 · EY · contact PI